Ventures 1st Quarter 2019 MD&A 1 Indorama Ventures Public Company Ltd Management Discussion and Analysis 1st Quarter 2019 Highlights  Revenue $3.0 billion (THB 95.8 billion), +26% YoY  Core EBITDA of $304

Indorama Ventures 1st Quarter 2019 MD&A 1 Indorama Ventures Public Company Ltd Management Discussion and Analysis 1st Quarter 2019 Highlights  Revenue $3.0 billion (THB 95.8 billion), +26% YoY  Core EBITDA

นโยบายและกลยุทธการลงทุน • กองทุนจะลงทุนในกองทุน iShares Core S&P 500 ETF (กองทุนหลัก) ซ่ึงเปนกองทุนอีทีเอฟที่จดทะเบียนซ้ือขายใน ตลาดหลักทรัพยนิวยอรก (NYSE Arca) และมีนโยบายลงทุนเพ่ือสรางผลตอบแทนใหใกล

its business with honesty, fairness and integrity by strongly being concerned about the market integrity as a whole; (2) skill, care and diligence An intermediary shall conduct its business with due

with honesty, fairness and integrity by strongly being concerned about the market integrity as a whole; (2) skill, care and diligence An intermediary shall conduct its business with due skill, care and

integrity by strongly being concerned about the market integrity as a whole; (2) skill, care and diligence An intermediary shall conduct its business with due skill, care and diligence; 2 (3) management and

Section 133 Securities and Exchange Act B.E. 2535 Section 133. The securities company shall manage a private fund with honesty and care to preserve the interests of the person who has authorized the

Section 133 Securities and Exchange Act B.E. 2535 Section 133. The securities company shall manage a private fund with honesty and care to preserve the interests of the person who has authorized the

of shareholding proportion by buying of 23% newly issued common shares of Ekachai International Co., Ltd., which is Ekachai Medical Care PCL. subsidiary. To : Directors and Manager The Stock Exchange

สัปดาห์” บนเว็บไซต์สำนักงานแทน ( https://www.sec.or.th/TH/Pages/WeeklyReport.aspx ) ขออภัยในความไม่สะดวกมา ณ ที่นี้ หน้าหลัก Cookie Care and Share